Research ArticleArticle
S 18126 ({2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl}), a Potent, Selective and Competitive Antagonist at Dopamine D4 Receptors: An In Vitro andIn Vivo Comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2,3b]pyridine) and Raclopride
Mark J. Millan, Adrian Newman-Tancredi, Mauricette Brocco, Alain Gobert, Françoise Lejeune, Valérie Audinot, Jean-Michel Rivet, Rudy Schreiber, Anne Dekeyne, Michael Spedding, Jean-Paul Nicolas and Jean-Louis Peglion
Journal of Pharmacology and Experimental Therapeutics October 1998, 287 (1) 167-186;
Mark J. Millan
Adrian Newman-Tancredi
Mauricette Brocco
Alain Gobert
Françoise Lejeune
Valérie Audinot
Jean-Michel Rivet
Rudy Schreiber
Anne Dekeyne
Michael Spedding
Jean-Paul Nicolas
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 287, Issue 1
1 Oct 1998
Research ArticleArticle
S 18126 ({2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl}), a Potent, Selective and Competitive Antagonist at Dopamine D4 Receptors: An In Vitro andIn Vivo Comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2,3b]pyridine) and Raclopride
Mark J. Millan, Adrian Newman-Tancredi, Mauricette Brocco, Alain Gobert, Françoise Lejeune, Valérie Audinot, Jean-Michel Rivet, Rudy Schreiber, Anne Dekeyne, Michael Spedding, Jean-Paul Nicolas and Jean-Louis Peglion
Journal of Pharmacology and Experimental Therapeutics October 1, 1998, 287 (1) 167-186;
Research ArticleArticle
S 18126 ({2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl}), a Potent, Selective and Competitive Antagonist at Dopamine D4 Receptors: An In Vitro andIn Vivo Comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2,3b]pyridine) and Raclopride
Mark J. Millan, Adrian Newman-Tancredi, Mauricette Brocco, Alain Gobert, Françoise Lejeune, Valérie Audinot, Jean-Michel Rivet, Rudy Schreiber, Anne Dekeyne, Michael Spedding, Jean-Paul Nicolas and Jean-Louis Peglion
Journal of Pharmacology and Experimental Therapeutics October 1, 1998, 287 (1) 167-186;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement